Label: ACNE BLU SALICYLIC ACID PADS- salicylic acid disc

  • NDC Code(s): 70547-200-90
  • Packager: INK Pharmaceuticals, Inc.
  • Category: HUMAN OTC DRUG LABEL
  • DEA Schedule: None
  • Marketing Status: OTC monograph final

DISCLAIMER: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.

Drug Label Information

Updated December 27, 2022

If you are a consumer or patient please visit this version.

  • Warnings

    For external use only

    Flammable until dry, keep away from extreme heat or open flame

    When using this product skin irritation and dryness is more likely to occur if you use another topical acne medication at the same time.  If irritation occurs, only use one topical acne medication at a time.  Avoid contact with the eyes, lips and mouth.  If contact occurs flush throughly with water.

    If swallowed, get medical help or contact a Poison Control Center right away.

  • Keep out of reach of children

    Keep out of reach of children

  • Active Ingredients

    Salicylic Acid   2%   Acne Treatment Pads

  • Uses

    For the treatment of acne.  Clears acne pimples, blackheads, whiteheads and acne blemishes.  Allows skin to heal.  Helps prevent new acne pimples, blackheads, whiteheads and acne blemishes.

  • Directions

    Clean the skin thoroughly before applying this product.  Gently wipe the entire affected area 1 to 3 times daily.  Because excessive drying of the skin may occur, start with 1 application daily, then gradually increase to 2 or 3 times daily if needed or as directed by a doctor.  If bothersome dryness or peeling occurs, reduce application to once a day or every other day.

  • Other Information

    Store in a dry, cool place but do not freeze.  Keep jar tightly closed

  • Inactive Ingredients

    Anthemis Nobilis (Chamomile) Flower Extract, Benzyl Alcohol, Butylene Glycol, Caprylic/Capric Triglycerides, Citrus Aurantium Dulcis Peel Oil, Citrus Grandis Peel Oil, Citrus Reticulata Peel Oil, Disodium EDTA, Ethanol, Ethoxydiglycol, FD&C Blue #1, Glycerin, Polysorbate 80, Sodium Hydroxide, Trans Resveratrol, Water, Xanthan Gum

  • Questions or comments?

    INK Pharmaceuticals, Inc. PO Box 26730, Overland Park, KS 66225, USA

    www.acneBLU.com

  • PRINCIPAL DISPLAY PANEL - 90 Pad Jar Label

    Clears & Prevents Acne and Acne Blemishes
    Calms and Moisturizes the Skin

    acne®
    BLU

    Maximum Strength Salicylic Acid & Resveratrol
    Acne Fighting & Preventing Pads

    Formulated and Tested by Dermatologists

    90 pads

    PRINCIPAL DISPLAY PANEL - 90 Pad Jar Label
  • INGREDIENTS AND APPEARANCE
    ACNE BLU SALICYLIC ACID PADS 
    salicylic acid disc
    Product Information
    Product TypeHUMAN OTC DRUGItem Code (Source)NDC:70547-200
    Route of AdministrationTOPICAL
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    SALICYLIC ACID (UNII: O414PZ4LPZ) (SALICYLIC ACID - UNII:O414PZ4LPZ) SALICYLIC ACID20 g  in 1000 g
    Inactive Ingredients
    Ingredient NameStrength
    WATER (UNII: 059QF0KO0R)  
    SODIUM HYDROXIDE (UNII: 55X04QC32I)  
    EDETATE DISODIUM (UNII: 7FLD91C86K)  
    GLYCERIN (UNII: PDC6A3C0OX)  
    XANTHAN GUM (UNII: TTV12P4NEE)  
    DIETHYLENE GLYCOL MONOETHYL ETHER (UNII: A1A1I8X02B)  
    ALCOHOL (UNII: 3K9958V90M)  
    FD&C BLUE NO. 1 (UNII: H3R47K3TBD)  
    BENZYL ALCOHOL (UNII: LKG8494WBH)  
    POLYSORBATE 80 (UNII: 6OZP39ZG8H)  
    RESVERATROL (UNII: Q369O8926L)  
    CHAMAEMELUM NOBILE FLOWER (UNII: O2T154T6OG)  
    MEDIUM-CHAIN TRIGLYCERIDES (UNII: C9H2L21V7U)  
    ORANGE PEEL (UNII: TI9T76XD44)  
    CITRUS MAXIMA FRUIT RIND OIL (UNII: 8U3877WD44)  
    MANDARIN OIL (UNII: NJO720F72R)  
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:70547-200-9090 in 1 JAR01/06/2020
    1113 g in 1 JAR; Type 0: Not a Combination Product
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    OTC monograph finalpart333D01/06/2020
    Labeler - INK Pharmaceuticals, Inc. (086964278)
    Registrant - Swiss-American CDMO, LLC (080170933)
    Establishment
    NameAddressID/FEIBusiness Operations
    TRI-PAC, INC.020844956manufacture(70547-200)